The risk of live vaccines for infants born to mothers on anti-TNF agents probably outweighs the benefit, the researcher added. “However at one year of age, infants exposed to anti-TNF-alpha in utero can receive live vaccines such as measles, mumps and rubella and varicella in order to protect the infant from potentially severe illness.”
Related Articles
A Better Family Plan
How to minimize the risks of pregnancy for women with SLE
Adalimumab & Infliximab Remain in Newborns after Delivery
A recent study showed that, when administered during pregnancy, infliximab takes longer to clear an infant’s system than adalimumab…
Rheumatologists Should Discuss with Patients Use of Immunomodulatory Agents During Pregnancy
The decision to continue or discontinue immunomodulatory medications during pregnancy is a difficult one for both patients and physicians. On the one hand, when left untreated, rheumatic conditions can cause harm to an unborn child, as well as to the pregnant mother. On the other hand, medications can be harmful to a developing fetus. In…
Treat to Target: Rheumatoid Arthritis in Pregnant Patients
A treat-to-target approach to managing rheumatoid arthritis can work even in pregnant women